Company Overview of Neurovance, Inc.
Key Executives for Neurovance, Inc.
|Jeffrey Allen Bailey||30 Relationships||Executive Chairman and Chief Executive Officer||53|
|Anthony A. McKinney M.B.A.||8 Relationships||Founder, Chief Development Officer and Director||--|
|William T. Pappafotopoulos MBA||No Relationships||Vice President of Finance and Administration||--|
|Brian Goff M.B.A.||7 Relationships||Chief Operating Officer and Director||47|
|Catherine O'Brien||No Relationships||Director of Clinical Operations||--|
Neurovance, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Jeffrey Allen Bailey||30 Relationships||Neurovance, Inc.||53|
|Anthony A. McKinney M.B.A.||8 Relationships||EBI Life Sciences, Inc.||--|
|Brian Goff M.B.A.||7 Relationships||Neurovance, Inc.||47|
|Campbell Murray M.D.||38 Relationships||Novartis Venture Fund||39|
|Paul M. K. Weiss Ph.D., MBA||76 Relationships||ProCertus BioPharm, Inc.||59|
Neurovance, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.